Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel

50 Páginas.

Autores:
Bonilla Solano, Nohora Patricia
Tipo de recurso:
Fecha de publicación:
2012
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
spa
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/9422
Acceso en línea:
http://www.ninds.nih.gov/find_people/groups/stroke_prg/2012-stroke-prg-full-report.htm#EPI
http://hdl.handle.net/10818/9422
Palabra clave:
Enfermedad cerebrovascular
Apoplejia
Desórdenes cerebrovasculares
Rights
License
http://purl.org/coar/access_right/c_abf2
id REPOUSABA2_84e1aece58f3df23685786b2c37dd514
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/9422
network_acronym_str REPOUSABA2
network_name_str Repositorio Universidad de la Sabana
repository_id_str
dc.title.es_CO.fl_str_mv Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
title Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
spellingShingle Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
Enfermedad cerebrovascular
Apoplejia
Desórdenes cerebrovasculares
title_short Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
title_full Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
title_fullStr Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
title_full_unstemmed Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
title_sort Estudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivel
dc.creator.fl_str_mv Bonilla Solano, Nohora Patricia
dc.contributor.author.none.fl_str_mv Bonilla Solano, Nohora Patricia
dc.subject.none.fl_str_mv Enfermedad cerebrovascular
Apoplejia
Desórdenes cerebrovasculares
topic Enfermedad cerebrovascular
Apoplejia
Desórdenes cerebrovasculares
description 50 Páginas.
publishDate 2012
dc.date.created.none.fl_str_mv 2012
dc.date.accessioned.none.fl_str_mv 2013-12-16T20:53:04Z
dc.date.available.none.fl_str_mv 2013-12-16T20:53:04Z
dc.date.issued.none.fl_str_mv 2013-12-16
dc.type.none.fl_str_mv bachelorThesis
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.local.none.fl_str_mv Tesis de especialización
dc.type.hasVersion.none.fl_str_mv publishedVersion
dc.identifier.citation.none.fl_str_mv Lackland, Daniel et al. Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2012.
Mukherjee D, Patil C. Epidemiology and the global burden of stroke. World Neurosurgery. 2011;76(65):585-590
Johnston CS et al. Global Variation in stroke burden and mortality: estimates from monitoring, surveillance and modeling. Lancet neurology. 2009; 8: 345-354.
Lavados, P et al. Stroke epidemiology, prevention and management strategies at regional level: Latin America and the Caribbean. Lancet Neurology. 2007;6:362-372.
Nicolau J, et al. Cardiovascular clinical research in South America. American Heart Journal. 2013;165:848-853.
Kuller LH. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev. 2000;22: 7-14
Howard VJ, et al. The reasons for geographic and racial differences in stroke study REGARDS: objectives and design. Neuroepidemiology. 2005; 25 : 135 – 143.
Rosamond W, et al. Heart disease and stroke statistics -2008 update: a report from the American heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146
Thorvaldsen P. et al. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367.
Rothwell PM. The high cost of not funding Stroke research: a comparison with heart disease and cancer. Lancet. 2001;357:1612-1616.
Hisham N, et al. Epidemiology, Pathophysiology and treatment of hypertension in Ischaemic stroke patients. Journal of stroke and cerebrovascular diseases. 2012. In press.
Ministerio de Salud y Protección Social. Universidad Nacional de Colombia. Situación de Salud en Colombia. 2005
Adams, Harold et al. Guidelines for the early management of adult with ischemic stroke. Stroke. 2007, 38:1655-1711.
Brown DL, et al. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovas Dis. 2003; 12 : 119-126
Ji-Guang W, et al. Antihypertensive treatment and prevention of stroke and dementia. Seminars in Cerebrovascular Diseases and Stroke. 2003;3(3):155-164
PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressurelowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
. Amarenco, P et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 335:549-559.
Yusuf S, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. ONTARGET. N Engl J Med. 2008;358:1547-1559
Fox KM, et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary heart disease: randomized, double-blind, placebo –controlled, multicenter trial (the EUROPA study). Lancet. 2003;362:782-788.
Silva S F, et al. Estudio de correlación entre marcadores de inflamación y grosor íntima media carotídeo, en pacientes con ataque cerebrovascular isquémico. Análisis submuestral del proyecto multicéntrico: Prevalencia de factores de riesgo para enfermedad cerebrovascular isquémica aguda – Estudio FREC VI. Acta Neurol Colomb. 2006;22(1):1-11.
Silva S F, et al. Ausencia de asociación entre obesidad y sobrepeso con enfermedad cerebrovascular isquémica aguda en una muestra de población colombiana. Acta Neurol Colomb. 2010;26(2):65-73.
Mogensen UB, et al. Cause-specific mortality after stroke: relation to age, sex, stroke severity and risk factors in a 10-year follow-up study. Journal of stroke and cerebrovascular diseases. 2012. In press.
Holzemer EM, et al. Modifying risk factors after TIA and Stroke: The impact of intensive education. The journal of nurse practitioners. 2011;7(5)372-377.
Silva AM, et al. Effects of a physical activity and healthy eating intervention to reduce stroke risk factors in older adults. Preventive Medicine. 2013. In press
Guía Neurológica 8: Enfermedad Cerebrovascular. Capítulo 2: Comportamiento epidemiológico de la Enfermedad Cerebrovascular en la Población Colombiana. Sociedad Colombiana de Neurología. Págs. 21-29.
Pradilla G et al. Estudio neuroepidemiológico piloto. Neurología Col.. 1984; 8: 133-139.
Zúñiga A et al. Prevalencia de las enfermedades neurológicas en Jamundí, Valle, Colombia. Colombia Med. 1986; 17:152- 153.
Pradilla G. et al. Estudio neuroepidemiológico de la comunidad rural del Hato. Médicas UIS. 1991; 4: 181-187.
Uribe C. et al. Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993). Rev Neurol. 1997; 25: 1008 – 1012.
Daza J, et al. Estudio epidemiológico en Juan de Acosta (Atlántico, Colombia). Acta Med Colomb. 1992; 17:324.
Pradilla G, et al. Estudio neuroepidemiológico nacional EPINEURO colombiano. Rev panam Salud Publica. 2003: 14; 104 – 111.
Pradilla G et al. Estudio neuroepidemiológico y toxicológico de una población minera con exposición crónica al mercurio. Acta Med Colomb. 1992; 17: 322
Pradilla G et al. Estudio neuroepidemiológico en comunidad urbana de Piedecuesta Santander. Acta Med Colom. 2002; 27: 407 – 420.
Saposnik G. y Del Brutto O. Stroke in South America: A systematic review of incidence, prevalence, and Stroke subtypes. Stroke. 2003;34:2103 – 2107.
Alireza A. Ischemic Stroke: Pathophysiology and principles of localization. Neurology. 2009;13:2-14
Fisher M, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253-7.
Jones W, et al. Hypertension and cerebrovascular disease. Seminars in cerebrovascular diseases. 2003;3(3):144-154
Jackson C et al. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and non lacunar infarcts. Stroke. 2005;36:891-904.
Ahmed N, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: and updated analysis from SITS-ISTR. Lancet Neurology. 2010;9:866-874.
Ouriques SC, et al. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries. Journal of stroke and cerebrovascular diseases. 2011;20(5):459-464.
Porcello LC, et al. Risk Factors among Stroke subtypes in Brazil. Journal of stroke and cerebrovascular diseases.2012;22(1):32-35
Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503
Adams HP Jr et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke.1993;24-35-41
Cantu-Brito C et al. Atherothrombotic Disease, Traditional Risk Factors, and 4- year Mortality in a Latin American Population: The REACH Registry. Clin Cardiol. 2012
Romano JG, et al. Disparities in stroke type and vascular risk factors between 2 hispanic populations in Miami and Mexico City. Journal of stroke and cerebrovascular diseases. 2013;22(6):828-833.
Saposnik G. y Del Brutto O. Stroke in South America: A systematic review of incidence, prevalence, and Stroke subtypes. Stroke. 2003;34:2103 – 2107.
Ramírez F, et al. Glicemia alterada en ayuno es el factor de riesgo más sensible de enfermedad aterosclerótica coronaria en pacientes colombianos con angina pectoris. Acta Med Colom. 2004;29:302-311.
Cardona J et al. Hypertension risk factor in health workers in Manizales – Colombia. Rev.fac med unal. Vol.56 no.1 Bogotá Ene./Mar. 2008
Manzur F. et al. Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la Costa Caribe Colombiana (Estudio Caribe). Rev. Col Cardiol. 2005; 12: 122-128
O`Donell MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic Stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376;112-123
Guía Neurológica 8: Enfermedad Cerebrovascular. Capítulo 2: Comportamiento epidemiológico de la Enfermedad Cerebrovascular en la Población Colombiana. Sociedad Colombiana de Neurología. Págs. 21-29.
Papademetriou V et al. Stroke prevention with the angiotensin II type 1.receptor blocker candesartan in elderly patients with isolated systolic hypertension. SCOPE. Journal of the American college of cardiology. 2004;44(6):1175-80.
Moran A, et al. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: The Coronary Heart Disease Policy Model. International Journal of Cardiology. 2011;150:332-337
Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503.
Brenner DA, et al. Awareness, treatment, and control of vascular risk factors among stroke survivors. Journal of stroke and cerebrovascular diseases. 2010;19(4):311-320.
Mendivil CO, et al. Valoración del riesgo cardiovascular global y prevalencia de dislipidemias según los criterios del NCEP-ATP III en una población adulta de Bogotá, Colombia. Clin Invest Arterioscl. 2004;16(3):99-107
Parsons M, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic Stroke. The New England Journal of Medicine. 2012;366:1099-1107.
Fuentes B, et al. Guidelines for the preventive treatment of ischaemic stroke and TIA. Neurología. 2012;27(9):560-574.
http://www.ninds.nih.gov/find_people/groups/stroke_prg/2012-stroke-prg-full-report.htm#EPI
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10818/9422
dc.identifier.local.none.fl_str_mv 256851
TE06289
identifier_str_mv Lackland, Daniel et al. Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2012.
Mukherjee D, Patil C. Epidemiology and the global burden of stroke. World Neurosurgery. 2011;76(65):585-590
Johnston CS et al. Global Variation in stroke burden and mortality: estimates from monitoring, surveillance and modeling. Lancet neurology. 2009; 8: 345-354.
Lavados, P et al. Stroke epidemiology, prevention and management strategies at regional level: Latin America and the Caribbean. Lancet Neurology. 2007;6:362-372.
Nicolau J, et al. Cardiovascular clinical research in South America. American Heart Journal. 2013;165:848-853.
Kuller LH. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev. 2000;22: 7-14
Howard VJ, et al. The reasons for geographic and racial differences in stroke study REGARDS: objectives and design. Neuroepidemiology. 2005; 25 : 135 – 143.
Rosamond W, et al. Heart disease and stroke statistics -2008 update: a report from the American heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146
Thorvaldsen P. et al. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367.
Rothwell PM. The high cost of not funding Stroke research: a comparison with heart disease and cancer. Lancet. 2001;357:1612-1616.
Hisham N, et al. Epidemiology, Pathophysiology and treatment of hypertension in Ischaemic stroke patients. Journal of stroke and cerebrovascular diseases. 2012. In press.
Ministerio de Salud y Protección Social. Universidad Nacional de Colombia. Situación de Salud en Colombia. 2005
Adams, Harold et al. Guidelines for the early management of adult with ischemic stroke. Stroke. 2007, 38:1655-1711.
Brown DL, et al. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovas Dis. 2003; 12 : 119-126
Ji-Guang W, et al. Antihypertensive treatment and prevention of stroke and dementia. Seminars in Cerebrovascular Diseases and Stroke. 2003;3(3):155-164
PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressurelowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
. Amarenco, P et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 335:549-559.
Yusuf S, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. ONTARGET. N Engl J Med. 2008;358:1547-1559
Fox KM, et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary heart disease: randomized, double-blind, placebo –controlled, multicenter trial (the EUROPA study). Lancet. 2003;362:782-788.
Silva S F, et al. Estudio de correlación entre marcadores de inflamación y grosor íntima media carotídeo, en pacientes con ataque cerebrovascular isquémico. Análisis submuestral del proyecto multicéntrico: Prevalencia de factores de riesgo para enfermedad cerebrovascular isquémica aguda – Estudio FREC VI. Acta Neurol Colomb. 2006;22(1):1-11.
Silva S F, et al. Ausencia de asociación entre obesidad y sobrepeso con enfermedad cerebrovascular isquémica aguda en una muestra de población colombiana. Acta Neurol Colomb. 2010;26(2):65-73.
Mogensen UB, et al. Cause-specific mortality after stroke: relation to age, sex, stroke severity and risk factors in a 10-year follow-up study. Journal of stroke and cerebrovascular diseases. 2012. In press.
Holzemer EM, et al. Modifying risk factors after TIA and Stroke: The impact of intensive education. The journal of nurse practitioners. 2011;7(5)372-377.
Silva AM, et al. Effects of a physical activity and healthy eating intervention to reduce stroke risk factors in older adults. Preventive Medicine. 2013. In press
Guía Neurológica 8: Enfermedad Cerebrovascular. Capítulo 2: Comportamiento epidemiológico de la Enfermedad Cerebrovascular en la Población Colombiana. Sociedad Colombiana de Neurología. Págs. 21-29.
Pradilla G et al. Estudio neuroepidemiológico piloto. Neurología Col.. 1984; 8: 133-139.
Zúñiga A et al. Prevalencia de las enfermedades neurológicas en Jamundí, Valle, Colombia. Colombia Med. 1986; 17:152- 153.
Pradilla G. et al. Estudio neuroepidemiológico de la comunidad rural del Hato. Médicas UIS. 1991; 4: 181-187.
Uribe C. et al. Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993). Rev Neurol. 1997; 25: 1008 – 1012.
Daza J, et al. Estudio epidemiológico en Juan de Acosta (Atlántico, Colombia). Acta Med Colomb. 1992; 17:324.
Pradilla G, et al. Estudio neuroepidemiológico nacional EPINEURO colombiano. Rev panam Salud Publica. 2003: 14; 104 – 111.
Pradilla G et al. Estudio neuroepidemiológico y toxicológico de una población minera con exposición crónica al mercurio. Acta Med Colomb. 1992; 17: 322
Pradilla G et al. Estudio neuroepidemiológico en comunidad urbana de Piedecuesta Santander. Acta Med Colom. 2002; 27: 407 – 420.
Saposnik G. y Del Brutto O. Stroke in South America: A systematic review of incidence, prevalence, and Stroke subtypes. Stroke. 2003;34:2103 – 2107.
Alireza A. Ischemic Stroke: Pathophysiology and principles of localization. Neurology. 2009;13:2-14
Fisher M, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253-7.
Jones W, et al. Hypertension and cerebrovascular disease. Seminars in cerebrovascular diseases. 2003;3(3):144-154
Jackson C et al. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and non lacunar infarcts. Stroke. 2005;36:891-904.
Ahmed N, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: and updated analysis from SITS-ISTR. Lancet Neurology. 2010;9:866-874.
Ouriques SC, et al. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries. Journal of stroke and cerebrovascular diseases. 2011;20(5):459-464.
Porcello LC, et al. Risk Factors among Stroke subtypes in Brazil. Journal of stroke and cerebrovascular diseases.2012;22(1):32-35
Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503
Adams HP Jr et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke.1993;24-35-41
Cantu-Brito C et al. Atherothrombotic Disease, Traditional Risk Factors, and 4- year Mortality in a Latin American Population: The REACH Registry. Clin Cardiol. 2012
Romano JG, et al. Disparities in stroke type and vascular risk factors between 2 hispanic populations in Miami and Mexico City. Journal of stroke and cerebrovascular diseases. 2013;22(6):828-833.
Ramírez F, et al. Glicemia alterada en ayuno es el factor de riesgo más sensible de enfermedad aterosclerótica coronaria en pacientes colombianos con angina pectoris. Acta Med Colom. 2004;29:302-311.
Cardona J et al. Hypertension risk factor in health workers in Manizales – Colombia. Rev.fac med unal. Vol.56 no.1 Bogotá Ene./Mar. 2008
Manzur F. et al. Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la Costa Caribe Colombiana (Estudio Caribe). Rev. Col Cardiol. 2005; 12: 122-128
O`Donell MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic Stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376;112-123
Papademetriou V et al. Stroke prevention with the angiotensin II type 1.receptor blocker candesartan in elderly patients with isolated systolic hypertension. SCOPE. Journal of the American college of cardiology. 2004;44(6):1175-80.
Moran A, et al. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: The Coronary Heart Disease Policy Model. International Journal of Cardiology. 2011;150:332-337
Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503.
Brenner DA, et al. Awareness, treatment, and control of vascular risk factors among stroke survivors. Journal of stroke and cerebrovascular diseases. 2010;19(4):311-320.
Mendivil CO, et al. Valoración del riesgo cardiovascular global y prevalencia de dislipidemias según los criterios del NCEP-ATP III en una población adulta de Bogotá, Colombia. Clin Invest Arterioscl. 2004;16(3):99-107
Parsons M, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic Stroke. The New England Journal of Medicine. 2012;366:1099-1107.
Fuentes B, et al. Guidelines for the preventive treatment of ischaemic stroke and TIA. Neurología. 2012;27(9):560-574.
256851
TE06289
url http://www.ninds.nih.gov/find_people/groups/stroke_prg/2012-stroke-prg-full-report.htm#EPI
http://hdl.handle.net/10818/9422
dc.language.iso.es_CO.fl_str_mv spa
language spa
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://purl.org/coar/access_right/c_abf2
dc.publisher.none.fl_str_mv Universidad de La Sabana
dc.publisher.program.none.fl_str_mv Especialización en Medicina Interna
dc.publisher.department.none.fl_str_mv Facultad de Medicina
publisher.none.fl_str_mv Universidad de La Sabana
dc.source.none.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
bitstream.url.fl_str_mv https://intellectum.unisabana.edu.co/bitstream/10818/9422/1/Nohora%20Patricia%20Bonilla%20Solano%28Tesis%29.pdf
https://intellectum.unisabana.edu.co/bitstream/10818/9422/2/license.txt
https://intellectum.unisabana.edu.co/bitstream/10818/9422/4/Nohora%20Patricia%20Bonilla%20Solano%20%28Carta%29.pdf
https://intellectum.unisabana.edu.co/bitstream/10818/9422/3/Nohora%20Patricia%20Bonilla%20Solano%28Tesis%29.pdf.txt
bitstream.checksum.fl_str_mv 21685f081b9fcc0607db0b9f0680f303
f52a2cfd4df262e08e9b300d62c85cab
d4b6d9b421f44bc9e077b20f313d79bc
b6997699b324cbe5385f0ceed53d740a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Intellectum Universidad de la Sabana
repository.mail.fl_str_mv contactointellectum@unisabana.edu.co
_version_ 1811952232645525504
spelling Bonilla Solano, Nohora PatriciaEspecialista en Medicina Interna2013-12-16T20:53:04Z2013-12-16T20:53:04Z20122013-12-16Lackland, Daniel et al. Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2012.Mukherjee D, Patil C. Epidemiology and the global burden of stroke. World Neurosurgery. 2011;76(65):585-590Johnston CS et al. Global Variation in stroke burden and mortality: estimates from monitoring, surveillance and modeling. Lancet neurology. 2009; 8: 345-354.Lavados, P et al. Stroke epidemiology, prevention and management strategies at regional level: Latin America and the Caribbean. Lancet Neurology. 2007;6:362-372.Nicolau J, et al. Cardiovascular clinical research in South America. American Heart Journal. 2013;165:848-853.Kuller LH. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev. 2000;22: 7-14Howard VJ, et al. The reasons for geographic and racial differences in stroke study REGARDS: objectives and design. Neuroepidemiology. 2005; 25 : 135 – 143.Rosamond W, et al. Heart disease and stroke statistics -2008 update: a report from the American heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146Thorvaldsen P. et al. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367.Rothwell PM. The high cost of not funding Stroke research: a comparison with heart disease and cancer. Lancet. 2001;357:1612-1616.Hisham N, et al. Epidemiology, Pathophysiology and treatment of hypertension in Ischaemic stroke patients. Journal of stroke and cerebrovascular diseases. 2012. In press.Ministerio de Salud y Protección Social. Universidad Nacional de Colombia. Situación de Salud en Colombia. 2005Adams, Harold et al. Guidelines for the early management of adult with ischemic stroke. Stroke. 2007, 38:1655-1711.Brown DL, et al. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovas Dis. 2003; 12 : 119-126Ji-Guang W, et al. Antihypertensive treatment and prevention of stroke and dementia. Seminars in Cerebrovascular Diseases and Stroke. 2003;3(3):155-164PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressurelowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.. Amarenco, P et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 335:549-559.Yusuf S, et al. Telmisartan, ramipril or both in patients at high risk for vascular events. ONTARGET. N Engl J Med. 2008;358:1547-1559Fox KM, et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary heart disease: randomized, double-blind, placebo –controlled, multicenter trial (the EUROPA study). Lancet. 2003;362:782-788.Silva S F, et al. Estudio de correlación entre marcadores de inflamación y grosor íntima media carotídeo, en pacientes con ataque cerebrovascular isquémico. Análisis submuestral del proyecto multicéntrico: Prevalencia de factores de riesgo para enfermedad cerebrovascular isquémica aguda – Estudio FREC VI. Acta Neurol Colomb. 2006;22(1):1-11.Silva S F, et al. Ausencia de asociación entre obesidad y sobrepeso con enfermedad cerebrovascular isquémica aguda en una muestra de población colombiana. Acta Neurol Colomb. 2010;26(2):65-73.Mogensen UB, et al. Cause-specific mortality after stroke: relation to age, sex, stroke severity and risk factors in a 10-year follow-up study. Journal of stroke and cerebrovascular diseases. 2012. In press.Holzemer EM, et al. Modifying risk factors after TIA and Stroke: The impact of intensive education. The journal of nurse practitioners. 2011;7(5)372-377.Silva AM, et al. Effects of a physical activity and healthy eating intervention to reduce stroke risk factors in older adults. Preventive Medicine. 2013. In pressGuía Neurológica 8: Enfermedad Cerebrovascular. Capítulo 2: Comportamiento epidemiológico de la Enfermedad Cerebrovascular en la Población Colombiana. Sociedad Colombiana de Neurología. Págs. 21-29.Pradilla G et al. Estudio neuroepidemiológico piloto. Neurología Col.. 1984; 8: 133-139.Zúñiga A et al. Prevalencia de las enfermedades neurológicas en Jamundí, Valle, Colombia. Colombia Med. 1986; 17:152- 153.Pradilla G. et al. Estudio neuroepidemiológico de la comunidad rural del Hato. Médicas UIS. 1991; 4: 181-187.Uribe C. et al. Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993). Rev Neurol. 1997; 25: 1008 – 1012.Daza J, et al. Estudio epidemiológico en Juan de Acosta (Atlántico, Colombia). Acta Med Colomb. 1992; 17:324.Pradilla G, et al. Estudio neuroepidemiológico nacional EPINEURO colombiano. Rev panam Salud Publica. 2003: 14; 104 – 111.Pradilla G et al. Estudio neuroepidemiológico y toxicológico de una población minera con exposición crónica al mercurio. Acta Med Colomb. 1992; 17: 322Pradilla G et al. Estudio neuroepidemiológico en comunidad urbana de Piedecuesta Santander. Acta Med Colom. 2002; 27: 407 – 420.Saposnik G. y Del Brutto O. Stroke in South America: A systematic review of incidence, prevalence, and Stroke subtypes. Stroke. 2003;34:2103 – 2107.Alireza A. Ischemic Stroke: Pathophysiology and principles of localization. Neurology. 2009;13:2-14Fisher M, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253-7.Jones W, et al. Hypertension and cerebrovascular disease. Seminars in cerebrovascular diseases. 2003;3(3):144-154Jackson C et al. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and non lacunar infarcts. Stroke. 2005;36:891-904.Ahmed N, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: and updated analysis from SITS-ISTR. Lancet Neurology. 2010;9:866-874.Ouriques SC, et al. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries. Journal of stroke and cerebrovascular diseases. 2011;20(5):459-464.Porcello LC, et al. Risk Factors among Stroke subtypes in Brazil. Journal of stroke and cerebrovascular diseases.2012;22(1):32-35Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503Adams HP Jr et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke.1993;24-35-41Cantu-Brito C et al. Atherothrombotic Disease, Traditional Risk Factors, and 4- year Mortality in a Latin American Population: The REACH Registry. Clin Cardiol. 2012Romano JG, et al. Disparities in stroke type and vascular risk factors between 2 hispanic populations in Miami and Mexico City. Journal of stroke and cerebrovascular diseases. 2013;22(6):828-833.Saposnik G. y Del Brutto O. Stroke in South America: A systematic review of incidence, prevalence, and Stroke subtypes. Stroke. 2003;34:2103 – 2107.Ramírez F, et al. Glicemia alterada en ayuno es el factor de riesgo más sensible de enfermedad aterosclerótica coronaria en pacientes colombianos con angina pectoris. Acta Med Colom. 2004;29:302-311.Cardona J et al. Hypertension risk factor in health workers in Manizales – Colombia. Rev.fac med unal. Vol.56 no.1 Bogotá Ene./Mar. 2008Manzur F. et al. Estudio sociológico y del conocimiento de los factores de riesgo de las enfermedades cardiovasculares en la Costa Caribe Colombiana (Estudio Caribe). Rev. Col Cardiol. 2005; 12: 122-128O`Donell MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic Stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376;112-123Guía Neurológica 8: Enfermedad Cerebrovascular. Capítulo 2: Comportamiento epidemiológico de la Enfermedad Cerebrovascular en la Población Colombiana. Sociedad Colombiana de Neurología. Págs. 21-29.Papademetriou V et al. Stroke prevention with the angiotensin II type 1.receptor blocker candesartan in elderly patients with isolated systolic hypertension. SCOPE. Journal of the American college of cardiology. 2004;44(6):1175-80.Moran A, et al. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: The Coronary Heart Disease Policy Model. International Journal of Cardiology. 2011;150:332-337Ratanakorn D, et al. Prevalence and association between risk factors, stroke subtypes and abnormal brachial index in acute ischemic stroke. Journal of stroke and cerebrovascular diseases. 2012;21(6):498-503.Brenner DA, et al. Awareness, treatment, and control of vascular risk factors among stroke survivors. Journal of stroke and cerebrovascular diseases. 2010;19(4):311-320.Mendivil CO, et al. Valoración del riesgo cardiovascular global y prevalencia de dislipidemias según los criterios del NCEP-ATP III en una población adulta de Bogotá, Colombia. Clin Invest Arterioscl. 2004;16(3):99-107Parsons M, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic Stroke. The New England Journal of Medicine. 2012;366:1099-1107.Fuentes B, et al. Guidelines for the preventive treatment of ischaemic stroke and TIA. Neurología. 2012;27(9):560-574.http://www.ninds.nih.gov/find_people/groups/stroke_prg/2012-stroke-prg-full-report.htm#EPIhttp://hdl.handle.net/10818/9422256851TE0628950 Páginas.INTRODUCCIÓN. La epidemiología y las características clínicas de la Enfermedad Cerebrovascular (ECV) varían de acuerdo a factores ambientales, raciales, de género y socioculturales; por tal razón, el conocimiento de la epidemiología de factores de riesgo para ECV en nuestra población tiene gran importancia y aporta elementos clave en términos de salud pública. OBJETIVOS. Determinar la prevalencia de los factores de riesgo para desarrollo de ECV y su tiempo de evolución, así como el número de pacientes recibiendo tratamiento para dichos factores de riesgo, la adherencia al mismo y el seguimiento de recomendaciones de dieta y actividad física. MATERIALES Y MÉTODOS. Se realizó un estudio observacional, tipo serie de casos, en pacientes mayores de 18 años que consultaron por ECV isquémico en el periodo de tiempo comprendido entre Enero de 2009 hasta Septiembre de 2013. Los pacientes se identificaron a través de los códigos CIE-10 en la base de datos de la para obtener aquellos registros con diagnóstico principal o relacionado de Enfermedad Cerebrovascular Isquémica. De esta manera 220 pacientes cumplieron los criterios de inclusión. Para la recolección de la información se diseñó un cuestionario que se aplicó a cada una de las historias clínicas. La información recolectada se consignó en una base de datos en Excel. Se realizó un análisis descriptivo utilizando el programa estadístico STATA versión 12.0. Se estimaron medidas de tendencia central y dispersión para variables continuas así como proporciones y frecuencias para variables ordinales y nominales.spaUniversidad de La SabanaEspecialización en Medicina InternaFacultad de MedicinaUniversidad de La SabanaIntellectum Repositorio Universidad de La SabanaEnfermedad cerebrovascularApoplejiaDesórdenes cerebrovascularesEstudio de prevalencia de los factores de riesgo asociados al desarrollo de enfermedad cerebrovascular isquémica no embolica en un hospital de tercer nivelbachelorThesisTesis de especializaciónpublishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/access_right/c_abf2ORIGINALNohora Patricia Bonilla Solano(Tesis).pdfNohora Patricia Bonilla Solano(Tesis).pdfVer documento en PDFapplication/pdf844815https://intellectum.unisabana.edu.co/bitstream/10818/9422/1/Nohora%20Patricia%20Bonilla%20Solano%28Tesis%29.pdf21685f081b9fcc0607db0b9f0680f303MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-8498https://intellectum.unisabana.edu.co/bitstream/10818/9422/2/license.txtf52a2cfd4df262e08e9b300d62c85cabMD52Nohora Patricia Bonilla Solano (Carta).pdfNohora Patricia Bonilla Solano (Carta).pdfapplication/pdf191167https://intellectum.unisabana.edu.co/bitstream/10818/9422/4/Nohora%20Patricia%20Bonilla%20Solano%20%28Carta%29.pdfd4b6d9b421f44bc9e077b20f313d79bcMD54TEXTNohora Patricia Bonilla Solano(Tesis).pdf.txtNohora Patricia Bonilla Solano(Tesis).pdf.txtExtracted Texttext/plain50https://intellectum.unisabana.edu.co/bitstream/10818/9422/3/Nohora%20Patricia%20Bonilla%20Solano%28Tesis%29.pdf.txtb6997699b324cbe5385f0ceed53d740aMD5310818/9422oai:intellectum.unisabana.edu.co:10818/94222019-08-13 15:13:21.052Intellectum Universidad de la Sabanacontactointellectum@unisabana.edu.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

Publicaciones similares